| Code | CSB-MP1684HU3d7 |
| Abbreviation | Recombinant Human IGHE protein, partial (Active) |
| MSDS | |
| Size | $156 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
IgE constant region mediates allergic responses and immediate hypersensitivity through high-affinity binding to FcεRI on mast cells and basophils, making it a critical target for therapeutic antibody development and allergy research. This mammalian-expressed fragment spanning residues 104–427 demonstrates quantifiable antibody-binding activity with an EC50 of 3.097–4.487 ng/mL in functional ELISA, providing a validated basis for epitope mapping studies, competitive inhibition assays to screen blocking antibodies, and affinity characterization by surface plasmon resonance or biolayer interferometry. The construct supports drug discovery workflows targeting IgE-mediated pathways, including small-molecule and biologic inhibitor screening against the Fc region. With purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg, this protein meets the quality thresholds commonly required for ligand-binding assays and therapeutic antibody validation experiments where low background interference is essential.
There are currently no reviews for this product.